pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Latigo Biotherapeutics Inc · news · pharmadog
← back to Latigo Biotherapeutics Inc
News mentioning Latigo Biotherapeutics Inc
11
stories
Aug 10, 26
BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOs
biospace
Aug 7, 26
Latigo IPO raises nearly $350M for pain drug development
biopharma dive
Aug 7, 26
BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts
fiercebiotech
Aug 4, 26
Latigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s Journavx
fiercebiotech
Jul 31, 26
Chasing Vertex, Latigo reports non-opioid pain drug succeeds in key trial
endpoints
Jul 29, 26
STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx
stat
Jul 24, 26
Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
fiercebiotech
Jul 20, 26
Pain drugmaker Latigo outlines plans to go public
biopharma dive
Jul 20, 26
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
fiercebiotech
Jul 19, 26
Latigo preps IPO to fund non-opioid pain drug rival to Vertex’s Journax
fiercebiotech
May 12, 26
A year after Vertex’s big launch, pain drug research faces a pivotal moment
biopharma dive
